STAT
MAY 18, 2024
To encourage robust, good-faith discussion about difficult issues, STAT publishes selected Letters to the Editor received in response to First Opinion essays. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “An AI-based second opinion service could improve clinical decision-making today,” by Adam Rodman and Arjun K.
Drug Patent Watch
MAY 18, 2024
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MAY 18, 2024
Researchers from the University of Manchester have developed a technique using rotaxane actuators in force-controlled release systems, enabling precise and efficient release of multiple molecules simultaneously.
Drug Patent Watch
MAY 18, 2024
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
MAY 18, 2024
Antimicrobial Resistance (AMR) continues to impact the efficacy of antibiotics – resulting in a serious potential threat to global population health. According to the UN , “AMR could push 28.3 million people into extreme poverty by 2050 due to high treatment costs and chronic infections.” That means there is a clear opportunity for collaboration to address this challenge and enhance pharmaceutical sustainability, benefiting people and the planet.
Drug Patent Watch
MAY 18, 2024
Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
MAY 18, 2024
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA.
PharmaTech
MAY 18, 2024
Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, Regeneron, discussed the utility of AI and how it can benefit R&D work.
The Happy PharmD
MAY 18, 2024
Pharmacists today are increasingly eyeing opportunities in the pharmaceutical industry, seeking to leverage their clinical knowledge in new and rewarding ways. Many are drawn to pharma as a pathway away from the traditional demands of patient care, intrigued by the breadth of roles available and the potential for both career growth and financial rewards.
Expert insights. Personalized for you.
194 
Let's personalize your content